Intensity Therapeutics (INTS) Cash from Financing Activities (2023 - 2026)
Intensity Therapeutics (INTS) reported Cash from Financing Activities of $1.62 million for Q2 2026, down 56.6% from $3.74 million a year earlier but up 982.7% from the prior quarter.
Intensity Therapeutics (INTS) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Intensity Therapeutics' Cash from Financing Activities came in at $16.27 million, up 133.7% year-over-year; for FY2025, it was $18.56 million, up 540.1% from FY2024.
- Cash from Financing Activities has a three-year compound annual growth rate of 102.1% (FY2022 to FY2025).
- By year, Cash from Financing Activities came in at $2.9 million in FY2024 (-85.8%), $20.47 million in FY2023 (+809.9%) and $2.25 million in FY2022.
- Five-year quarterly Cash from Financing Activities spans a low of -$241,000 in Q2 2023 and a high of $20.52 million in Q3 2023.
- Year over year, Cash from Financing Activities gained in 1 of the last four quarters, with an average decline of 4.0%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $150,000 (Q1 2026), $7.26 million (Q4 2025) and $7.24 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Intensity Therapeutics | 10.75 Mn | 10.75 Mn | - | 1.62 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | 7.26 Mn |
| Sep 30, 2025 | 7.24 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 328,000.00 |
| Dec 31, 2024 | 2.48 Mn |
| Sep 30, 2024 | 413,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | -13,000.00 |
| Sep 30, 2023 | 20.52 Mn |
| Jun 30, 2023 | -241,000.00 |
| Mar 31, 2023 | 205,000.00 |
Intensity Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INTS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();